Gene Set: BILBAN_B_CLL_LPL_DN

Standard name BILBAN_B_CLL_LPL_DN
Systematic name M14940
Brief description Genes down-regulated in B-CLL (B-cell chronic leukemia) samples expressing high levels of LPL [GeneID=4023] compared with those expressing low levels of the gene.
Full description or abstract Lipoprotein lipase (LPL) is a prognostic marker in B-cell chronic lymphocytic leukemia (B-CLL) related to immunoglobulin V(H) gene (IgV(H))mutational status. We determined gene expression profiles using Affymetrix U133A GeneChips in two groups of B-CLLs selected for either high ('LPL+', n=10) or low ('LPL-', n=10) LPL mRNA expression. Selected genes were verified by real-time PCR in an extended patient cohort (n=42). A total of 111 genes discriminated LPL+ from LPL- B-CLLs. Of these, the top three genes associated with time to first treatment were Septin10, DMD and Gravin (P
Collection C2: curated gene sets
      CGP: chemical and genetic perturbations
Source publication Pubmed 16617321   Authors: Bilban M,Heintel D,Scharl T,Woelfel T,Auer MM,Porpaczy E,Kainz B,Kröber A,Carey VJ,Shehata M,Zielinski C,Pickl W,Stilgenbauer S,Gaiger A,Wagner O,Jäger U,LastName M
Exact source Table 1BS
Related gene sets (show 1 additional gene sets from the source publication)

(show 49 gene sets from the same authors)
External links  
Filtered by similarity
Organism Homo sapiens
Contributed by Arthur Liberzon (MSigDB Team)
Source platform AFFY_HG_U133
Dataset references  
Download gene set format: grp | text | gmt | gmx | xml
Compute overlaps (show collections to investigate for overlap with this gene set)
Compendia expression profiles GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Advanced query Further investigate these 42 genes
Gene families Categorize these 42 genes by gene family
Show members (show 48 members mapped to 42 genes)
Version history 3.0: First introduced

See MSigDB license terms here. Please note that certain gene sets have special access terms.